The Lead Episode 104: A Discussion of Implantable Loop Recorder and Arrhythmia Detection in Hypertrophic Cardiomyopathy

The Lead Episode 104: A Discussion of Implantable Loop Recorder and Arrhythmia Detection in Hypertrophic Cardiomyopathy - Live at HRS 2025

Description

Sandeep A Saha, MD, MS, FHRS, Oregon Heart Center PC is joined by Saket Sanghai, MD, FHRS, Oregon Health & Science University, and Krish Pothineni, MD, Kansas City Heart Rhythm Institute, to discuss how the study evaluated the effectiveness of implantable loop recorders (ILRs) in detecting arrhythmias in patients with hypertrophic cardiomyopathy (HCM). Traditional monitoring methods, like Holter monitors, often miss intermittent arrhythmic events in HCM patients. ILRs, offering continuous long-term monitoring, were found to identify clinically significant arrhythmias that might otherwise go undetected. The findings suggest that ILRs can play a crucial role in risk stratification and management of HCM patients, potentially guiding decisions regarding interventions such as implantable cardioverter-defibrillator (ICD) implantation. Overall, ILRs enhance the detection of arrhythmias in HCM, leading to improved patient care.

Learning Objectives

Evaluate the effectiveness of implantable loop recorders (ILRs) in detecting arrhythmias in patients with hypertrophic cardiomyopathy

Article Authors and Podcast Contributors

Article Authors

Omar M Abdelfattah, Deaa Abu Jazar, Arun Narayanan, Martin Maron, Ethan Rowin, Matthew W Martinez

Podcast Contributors

Sandeep A. Saha, MD, MS, FHRS, Oregon Heart Center PC
Saket Sanghai, MD, FHRS, Oregon Health & Science University
Krishna Pothineni, MD, Kansas City Heart Rhythm Institute

Faculty and Disclosures

All relevant financial relationships have been mitigated.

Host Disclosure(s):

S. Saha:
Honoraria/Speaking/Consulting Fee: Medtronic
Membership on Advisory Committees: Medtronic Inc.

Contributor Disclosure(s):

S. Sanghai:
Research: Siemens Healthcare
Stocks (Publicly Traded): Apple Inc., Alphabet Inc., Amazon
Stock Options (Publicly Traded): Intel

K. Pothineni:
Honoraria/Speaking/Consulting Fee: Medtronic, Inc., Biosense Webster, Inc., Boston Scientific

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered